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ABSTRACT
Background. Habitual alcohol drinking has been shown 
to be associated with incidental diabetes and glycemic 
status. The aim of this study was to determine the 
relationships between alcohol drinking and peripheral 
blood cell counts in patients with diabetes. 
Methods. The participants (n = 333) were Japanese 
male workers with diabetes aged 32–65 years (mean 
age: 52.9 years). Relationships of frequency of habitual 
alcohol drinking with peripheral blood cell-related 
variables were investigated in middle-aged men with 
diabetes.
Results. Erythrocyte and leukocyte counts were signifi-
cantly lower in regular drinkers than in nondrinkers, 
while platelet count, hemoglobin concentration and 
hematocrit were not significantly different between 
regular drinkers and nondrinkers. Mean corpuscular 
hemoglobin and mean corpuscular volume were sig-
nificantly higher in regular drinkers than in nondrink-
ers. Both serum γ-glutamyl transpeptidase and HDL 
cholesterol levels tended to be higher with an increase 
of frequency of drinking.
Conclusions: There are inverse associations of habitual 
alcohol drinking with erythrocyte count and leukocyte 
counts but not with platelet count in men with diabe-
tes. (Clin Diabetol 2021; 10)
Keywords: alcohol, diabetes, erythrocytes, 
leukocytes, platelets
Introduction
Alcohol drinking has been shown to be associated 
with incidental diabetes and glycemic status: According 
to previous meta-analysis studies, light-to-moderate 
alcohol drinking was shown to be inversely associated 
with incidence of type 2 diabetes, and there was a 
U-shaped relationship between amount of alcohol
intake and risk of diabetes [1–3]. Alcohol consumption 
has also been reported to be inversely associated with
hemoglobin A1c level in the general population [4–6].
Alcohol is known to influence peripheral blood 
cell counts. Alcohol use disorder (AUD), including 
both alcohol abuse and alcohol dependence, causes 
macrocytic (megaloblastic) anemia due to deficiency 
of folate [7]. Mean corpuscular volume (MCV), an 
index of erythrocyte size, is used as a biomarker for 
screening to detect AUD [8–10]. In addition, ineffective 
erythropoiesis associated with impaired iron utilization 
has been reported in bone marrow of patients with 
AUD [11]. In the general population, erythrocyte count 
and leukocyte count were reportedly lower in habitual 
drinkers than in nondrinkers [12, 13]. Platelet count has 
been shown to be lower in persons with AUD [14, 15] 
but not to be different in drinkers and nondrinkers in 
the general population [16].
Although the inverse associations of habitual 
drinking with erythrocyte and leukocyte counts in the 
general population were reported in several studies 
[12, 13, 16], it remains to be clarified whether and 
how peripheral blood cell counts are influenced by 
alcohol drinking in patients with diabetes. Patients with 
diabetes are vulnerable to infectious disease [17], and 
thrombosis is an important process in the pathophysiol-
ogy of cardiovascular disease [18], which is the most 
frequent complication that decides the prognosis of 
diabetes patients [19]. In addition, anemia is associated 
with mortality in patients with ischemic heart disease 
[20–22]. Thus, it would be of interest to know how pe-
ripheral leukocyte and platelet counts of patients with 
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diabetes are influenced by habitual alcohol drinking, 
which shows both harmful and beneficial effects on 
cardiovascular health: the risk of coronary heart disease 
is lower in light drinkers but is higher in heavy drinkers 
compared with nondrinkers [23]. The purpose of this 
concise study was therefore to determine the relation-
ships between habitual alcohol drinking and peripheral 
blood cell counts in men with diabetes.
Subjects and methods
Subjects
The participants in the original database were Japa-
nese male workers aged 30–65 years (n = 16014) who 
had received periodic health checkup examinations at 
workplaces in Yamagata Prefecture in Japan. This study 
was approved by the Hyogo College of Medicine Ethics 
Committee (No. 3003 in 2018). Histories of alcohol con-
sumption, cigarette smoking, illness, and therapy for 
illness were surveyed by questionnaires. Subjects of this 
study (n = 333) were men with diabetes [age: 32–65 
years (mean age: 52.9 years)] who were extracted from 
the above database according to the criteria for dia-
betes as described below. Those receiving therapy for 
anemia were excluded from the subjects of this study. 
Frequency of habitual alcohol drinking was asked 
in the questionnaire as “How frequently do you drink 
alcohol?” Frequency of weekly alcohol drinking was 
categorized as “every day” (regular drinkers), “some-
times” (occasional drinkers) and “never” (nondrinkers). 
The subjects were divided into four groups by average 
cigarette consumption (nonsmokers; light smokers, 
< 20 cigarettes per day; heavy smokers, ≥ 20 and < 40 
cigarettes per day; very heavy smokers, ≥ 40 cigarettes 
per day).
Measurements 
Height and body weight were measured with light 
clothes at the health checkup. Body mass index (BMI) 
was calculated as weight in kilograms divided by the 
square of height in meters. Waist circumference was 
measured at the navel level according to the recom-
mendation of the definition of the Japanese Committee 
for the Diagnostic Criteria of Metabolic Syndrome. [24]. 
Visceral obesity was evaluated by the ratio of waist 
circumference (cm) to height (cm). Fasted blood was 
collected from each subject in the morning and im-
mediately transferred to a 2-mL glass tube containing 
3.8 mg EDTA-2K. An automatic hematology analyzer 
(Sysmex XE-2100, Sysmex Corp., Kobe, Japan) was used 
for the following measurements of blood cell-related 
variables. Erythrocyte count and platelet count were 
measured by the electric resistance detecting method, 
and leukocyte count was measured by flow cytometry 
(with a red laser at 633 nm). Hemoglobin concentration 
and hematocrit were measured by the sodium lauryl 
sulfate (SLS) hemoglobin method and cumulative pulse 
height method, respectively. A part of the blood was 
collected into a plastic tube to obtain serum, and serum 
gamma-glutamyl transpeptidase (GGT) and HDL cho-
lesterol concentrations were measured by enzymatic 
methods using commercial kits, pureauto S GGT and 
cholestest N-HDL (Sekisui Medical Co., Ltd, Tokyo, Ja-
pan), respectively. Hemoglobin A1c was measured by 
the NGSP (National Glycohemoglobin Standardization 
Program)-approved technique using the latex cohe-
sion method with a commercial kit (Determiner HbA1c, 
Kyowa Medex, Tokyo, Japan). Since the standards of 
hemoglobin A1c used for measurement are different in 
the NGSP method and the JDS (Japan Diabetes Society) 
method, hemoglobin A1c values were calibrated by 
using a formula proposed by the JDS [25]: hemoglobin 
A1c (NGSP) (%) = 1.02 × hemoglobin A1c (JDS) (%) 
+ 0.25%. Participants with diabetes were defined as 
those receiving drug therapy for diabetes and/or those 
showing high hemoglobin A1c levels (≥ 6.5%).
Statistical analysis 
Statistical analyses were performed using a com- 
puter software program (SPSS version 16.0 J for 
Windows, Chicago IL, USA). Mean levels of each 
quantitative variable were compared using analysis of 
variance (ANOVA) followed by Scheffé’s F-test in uni-
variate analysis and analysis of covariance (ANCOVA) 
followed by Student’s t-test after Bonferroni correc-
tion in multivariate analysis. GGT levels did not show 
a normal distribution and were thus non-parametrically 
analyzed by using the Kruskal-Wallis test followed by 
the Steel-Dwass test as a post-hoc test in univariate 
analysis. Comparison of the percentages of each cat-
egorical variable between groups was performed using 
the chi-square test for independence. Age, history of 
smoking, BMI, GGT and hemoglobin A1c were used as 
other explanatory variables in ANCOVA. Probability (p) 
values less than 0.05 were defined as significant.
Results
Table 1 shows the characteristics of the subjects. 
The variables were compared among non-, occasional 
and regular drinker groups by univariate analyses. 
There were no significant differences among non-, 
occasional and regular drinkers in age, proportion of 
smokers, proportion of participants receiving medical 
therapy for diabetes and level of hemoglobin A1c. 
Obesity-related indices including BMI, waist circumfer-
ence and waist-to-height ratio were not significantly 
different in non-, occasional and regular drinkers. GGT 
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and HDL cholesterol levels were significantly higher in 
occasional and regular drinkers than in nondrinkers 
and were significantly higher in regular drinkers than in 
occasional drinkers. Erythrocyte count was significantly 
lower in regular drinkers than in nondrinkers and oc-
casional drinkers (mean with 95% confidence interval 
of erythrocyte count [× 104/μL]: 500.2 (491.4–509.1) 
in nondrinkers vs 498.5 (491.7–505.3) in occasional 
drinkers vs 485.2 (478.6–491.7) in regular drinkers], 
while hemoglobin concentration and hematocrit were 
not significantly different among the three drinker 
groups [hemoglobin (g/dL): 15.2 (14.9–15.5) in non-
drinkers vs 15.4 (15.2–15.6) in occasional drinkers vs 
15.4 (15.2–15.5) in regular drinkers; hematocrit [%]: 
45.6 (44.8–46.4) in nondrinkers vs 46.4 (45.8–47.0) in 
occasional drinkers vs 46.0 (45.5–46.6) in regular drink-
ers]. MCH (mean corpuscular hemoglobin) and MCV 
(mean corpuscular volume) were significantly higher 
in regular drinkers than in nondrinkers [MCH (pg): 
29.9 (29.5–30.3) in nondrinkers vs 31.3 (31.0–31.5) 
in regular drinkers; MCV [fL]: 91.3 (90.3–92.2) in 
nondrinkers vs 95.1 (94.3–95.9) in regular drinkers]. 
MCV was also significantly higher in regular drinkers 
than in occasional drinkers [93.3 (92.4–94.2) in oc-
casional drinkers]. Leukocyte count was significantly 
lower in regular drinkers than in nondrinkers [leukocyte 
count (/μL): 7531 (7037–8026) in nondrinkers vs 6438 
(6168–6707) in regular drinkers], while platelet count 
was not significantly different among the three drinker 
groups [platelet count (× 104/μL): 23.0 (21.7–24.3) in 
nondrinkers vs 22.5 (21.6–23.5) in occasional drinkers 
vs 22.6 (21.6–23.6) in regular drinkers].
Table 2 shows a comparison of each variable of pe-
ripheral blood cells and HDL cholesterol in multivariate 
analysis (ANCOVA) with adjustment for age, history of 
smoking, BMI, GGT and hemoglobin A1c. Erythrocyte 
count tended to be lower in regular drinkers than in 
non- and occasional drinkers, although not significant 
[erythrocyte count (× 104/μL): 497.6 (489.4–505.9) 
in nondrinkers vs 498.2 (491.8–504.6) in occasional 
drinkers vs 487.1 (480.6–493.5) in regular drinkers]. 
There were no significant differences in hemoglobin 
concentration and hematocrit in non-, occasional and 
regular drinkers [hemoglobin (g/dL): 15.2 (14.9–15.4) in 
nondrinkers vs 15.4 (15.2–15.6) in occasional drinkers 
vs 15.4 (15.2–15.6) in regular drinkers; hematocrit (%l): 
45.7 (44.9–46.4) in nondrinkers vs 46.4 (45.9–47.0) 
in occasional drinkers vs 46.0 (45.4–46.5) in regular 
drinkers]. MCH and MCV were significantly higher in 
regular drinkers than in nondrinkers [MCH (pg): 30.0 
(29.7–30.4) in nondrinkers vs 31.2 (30.9–31.5) in regu-
lar drinkers; MCV (fL): 91.9 (90.9–92.8) in nondrinkers 
vs 94.6 (93.8–95.4) in regular drinkers], and MCV 
was also significantly higher in regular drinkers than 
Table 1. Characteristics of each drinker group and overall subjects with diabetes
Nondrinkers Occasional drinkers Regular drinkers Overall subjects
Number 80 125 128 333
Age [years] 51.5 (49.5 ~ 53.5) 52.7 (51.3 ~ 54.1) 54.0 (52.8 ~ 55.2) 52.9 (52.1 ~ 53.8)
Smokers [%] 48.8 47.2 50.8 48.9
Therapy for diabetes [%] 55.0 55.2 47.7 52.3
Body mass index [kg/m2] 25.7 (24.8 ~ 26.7) 25.2 (24.4 ~ 26.0) 24.5 (23.9 ~ 25.1) 25.1 (24.6 ~ 25.5)
Waist circumference [cm] 88.3 (86.0 ~ 90.7) 87.9 (86.3 ~ 89.6) 86.2 (84.6 ~ 87.7) 87.3 (86.3 ~ 88.4)
Waist-to-height ratio 0.523 (0.510 ~ 0.536) 0.519 (0.509 ~ 0.529) 0.512 (0.503 ~ 0.520) 0.517 (0.511 ~ 0.523)
Hemoglobin A1c [%] 7.14 (6.74 ~ 7.53) 6.90 (6.56 ~ 7.23) 6.89 (6.56 ~ 7.22) 6.95 (6.75 ~ 7.15)
GGT [U/dL] 37.0 (22.5, 48.0) 43.0 (31.0, 84.0)** 57.5 (37.5, 95.0)**, † 46.0 (30.0, 80.5)
HDL cholesterol [mg/dL] 44.8 (42.8 ~ 46.8) 50.2 (48.2 ~ 52.2)* 57.1 (54.4 ~ 59.8)**,†† 51.5 (50.1 ~ 53.0)
Erythrocytes [x104/μL] 500.2 (491.4 ~ 509.1) 498.5 (491.7 ~ 505.3) 485.2 (478.6 ~ 491.7)*,† 493.8 (489.6 ~ 498.0)
Hemoglobin [g/dL] 15.2 (14.9 ~ 15.5) 15.4 (15.2 ~ 15.6) 15.4 (15.2 ~ 15.5) 15.3 (15.2 ~ 15.4)
Hematocrit [%] 45.6 (44.8 ~ 46.4) 46.4 (45.8 ~ 47.0) 46.0 (45.5 ~ 46.6) 46.1 (45.7 ~ 46.4)
MCH [pg] 29.9 (29.5 ~ 30.3) 30.4 (30.1 ~ 30.7) 31.3 (31.0 ~ 31.5)**,†† 30.6 (30.4 ~ 30.8)
MCV [fL] 91.3 (90.3 ~ 92.2) 93.3 (92.4 ~ 94.2)* 95.1 (94.3 ~ 95.9)**,† 93.5 (93.0 ~ 94.0)
Leukocytes [/μL] 7531 (7037 ~ 8026) 6880 (6546 ~ 7214) 6438 (6168 ~ 6707)** 6866 (6662 ~ 7071)
Platelets [× 104/μL] 23.0 (21.7 ~ 24.3) 22.5 (21.6 ~ 23.5) 22.6 (21.6 ~ 23.6) 22.7 (22.1 ~ 23.3) 
Shown are numbers of subjects, frequencies, and means with 95% confidence intervals in parentheses and medians with 25 and 75 percentile values in pa-
rentheses of each variable. BMI — body mass index; GGT — γ-glutamyltransferase; HDL — high-density lipoprotein; MCH — mean corpuscular hemoglobin; 
MCV — mean corpuscular volume. Each variable was compared among the groups by univariate analyses. Asterisks denote significant differences from 
nondrinkers (*p < 0.05; **p < 0.01) and occasional drinkers (†p < 0.05; ††p < 0.01)
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in occasional drinkers [93.4 (92.6–94.2) in occasional 
drinkers]. Leukocyte count was significantly lower in 
regular drinkers than in nondrinkers and tended to 
be lower with an increase in the frequency of alcohol 
drinking [leukocyte count (/μL): 7476 (7073–7880) in 
nondrinkers vs 6922 (6607–7238) in occasional drink-
ers vs 6431 (6113–6748) in regular drinkers], while 
platelet count was not significantly different among 
the three drinker groups [platelet count (×104/μL): 22.8 
(21.6–24.0) in nondrinkers vs 22.5 (21.6–23.5) in occa-
sional drinkers vs 22.7 (21.8–23.7) in regular drinkers]. 
HDL cholesterol was significantly higher in occasional 
and regular drinkers than in nondrinkers and was sig-
nificantly higher in regular drinkers than in occasional 
drinkers [HDL cholesterol (mg/dL): 45.6 (42.9–48.3) in 
nondrinkers vs 50.3 (48.2–52.4) in occasional drinkers 
vs 56.5 (54.4–58.6) in regular drinkers].
Discussion
This study showed for the first time the relation-
ships of habitual alcohol drinking with peripheral blood 
cell counts in men with diabetes. Erythrocyte count 
was lower in regular drinkers than in nondrinkers and 
occasional drinkers, and MCH and MCV were higher in 
regular drinkers than in nondrinkers, while hemoglobin 
concentration and hematocrit were not significantly 
different among the drinker groups. Since MCH and 
MCV are calculated by hemoglobin and hematocrit, 
respectively, with being divided by erythrocyte count, 
higher MCH and MCV in regular drinkers may reflect 
lower erythrocyte count in regular drinkers than in 
nondrinkers. Leukocyte count was also lower in regular 
drinkers than in nondrinkers, while platelet counts were 
comparable in the three drinking groups. Therefore, it 
is concluded that in persons with diabetes, erythrocyte 
count and leukocyte count are inversely associated with 
regular alcohol drinking, while there is no association 
between alcohol drinking and platelet count.
The significance of lower erythrocyte count and 
lower leukocyte count in habitual drinkers with diabetes 
remains unknown. Although the difference in eryth-
rocyte count between drinkers and nondrinkers was 
small, there was a considerable difference (about 1000/
μL) in leukocyte count of regular drinkers and nondrink-
ers. Lower leukocyte count is suspected to be related 
to the risks of infection and cardiovascular disease in 
patients with diabetes. There is a possible significance 
of lower leukocyte count in regular drinkers with dia-
betes as a reason for their vulnerability to infection. 
Another possibility is that lower leukocyte count reflects 
the anti-atherosclerotic action of alcohol that results in 
suppression of inflammatory responses in atheroscle-
rotic lesions [26]. In fact, men who consumed alcohol 
three to four or five to seven days per week have been 
shown to have decreased risks of myocardial infarction 
compared with the risks in men who consumed alcohol 
less than once per week [27]. However, it is not possible 
to conclude the changes in peripheral blood cell counts 
by alcohol in patients with diabetes since this study 
is a cross-sectional study. Therefore, future prospec-
tive studies using a larger population of subjects are 
needed to clarify causal relationships between alcohol 
drinking and peripheral blood cell counts in patients 
with diabetes. There is also a limitation of this study: 
comparisons of blood cell counts were performed only 
in the groups of subjects with different frequencies of 
drinking and were not performed in groups of sub-
jects with different amounts of alcohol drinking since 
the numbers of subjects in subgroups with different 
amounts of alcohol intake were not large enough for 
statistical analysis. GGT and HDL cholesterol are known 
to be sensitive to the amount of alcohol consumption 
Table 2. Comparisons of variables related to peripheral blood cells and HDL cholesterol among the drinker groups of 
subjects with diabetes by multivariate analysis
Nondrinkers Occasional drinkers Regular drinkers
Erythrocytes [× 104/μL] 497.6 (489.4 ~ 505.9) 498.2 (491.8 ~ 504.6) 487.1 (480.6 ~ 493.5)
Hemoglobin [g/dL] 15.2 (14.9 ~ 15.4) 15.4 (15.2 ~ 15.6) 15.4 (15.2 ~ 15.6)
Hematocrit [%] 45.7 (44.9 ~ 46.4) 46.4 (45.9 ~ 47.0) 46.0 (45.4 ~ 46.5)
MCH [pg] 30.0 (29.7 ~ 30.4) 30.4 (30.1 ~ 30.7) 31.2 (30.9 ~ 31.5)**,†
MCV [fL] 91.9 (90.9 ~ 92.8) 93.4 (92.6 ~ 94.2)* 94.6 (93.8 ~ 95.4)**
Leukocytes [/μL] 7476 (7073 ~ 7880) 6922 (6607 ~ 7238) 6431 (6113 ~ 6748)**
Platelets [×104/μL] 22.8 (21.6 ~ 24.0) 22.5 (21.6 ~ 23.5) 22.7 (21.8 ~ 23.7)
HDL cholesterol [mg/dL] 45.6 (42.9 ~ 48.3) 50.3 (48.2 ~ 52.4)* 56.5 (54.4 ~ 58.6)**,† 
Shown are means with 95% confidence intervals in parentheses of each variable after adjustment for age, history of smoking, BMI, GGT, and hemoglobin 
A1c in analysis of covariance. MCH, mean corpuscular hemoglobin; MCV, mean corpuscular volume. Symbols indicate significant differences from nondrink-
ers (*p < 0.05; **p < 0.01) and occasional drinker (†p < 0.01). HDL cholesterol is known to be sensitive to the amount of alcohol consumption [20]
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[28]. In the present study, there are clear associations 
of frequency of alcohol drinking with GGT and HDL 
cholesterol levels (Table 1), implying considerable 
differences in the amounts of alcohol intake of non-, 
occasional and regular drinkers. Therefore, it is easily 
expected that amount of alcohol intake is also inversely 
associated with erythrocyte count and leukocyte count.
Conclusions
There are inverse associations of regular drinking 
with erythrocyte and leukocyte counts in men with 
diabetes. Clinical significance of lower erythrocyte and 
leukocyte counts in habitual drinkers with diabetes 
remains to be elucidated. 
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